We conducted a mail survey of patients who had received cochlear impla nts to ascertain their ability to communicate on the telephone . Of86 pat ients who responded, 38 (44%) did not use the telephon e at all, 36 (42 %) were able to use the telephon e without assi stan ce (independent users), and 12 (14% ) were able to lise the telephon e with some type ofassistance. Factors asso ciated with independent lise were male sex, older age at the onset ofhearin g loss, longer duration of hearing loss , successful use of hearing aids prim' to cochlear implantation, implantation with a MED-EL Combi 40+ device, and a shorter duration ofimplant use. But regardl ess ofcircumsta nces, our findin gs suggest that many cochlear implant pati ents can lise the telephone dur ing daily activ ity without the need for assistive devices or relay services. From the Departm ent of Otolaryngology-Head and Ncc k Surgery (Dr. Adams, Dr. Pippin, and Dr. Sism ani s) a nd thc Audiology Cent er (Dr. Hasen stab), Vir gini a Commonw ealth Univer sity Health Systems, Medi cal Co llege of Virginia Hospit als and Physician s, Richm ond . Reprint reque sts: Dr. M. Su zanne Hascn stab , Virgini a Comm onw ealth University Health System s, Medic al College of Virginia Hospitals and Phy sici an s, PO Box 980 150. Richm ond , VA 23 298-0150 . Phon e: (804) 828-043 1; fax (804) 628 -0950; e-ma il: shascnstab@ hsc .vc u.cdu Origina lly pre se nted at thc scientific sess ions of thc Combi ned Otolaryngolog ical Sp ring Meeti ngs; May 11, 2002; Boca Rato n, Fla.
Introduction
Severe to profound hearing loss ca n limit or even preclude telephone communica tion, eve n among patients who use a hearing aid. Although studies have shown that coch lear implants have a positi ve effec t on speec h perce ption and speech prod uction in such patie nts,I telephone competency is more difficult to achieve . Co mmunicatio n by telephone requires understanding speech without v\sual cues in an enviro nment of transmi ssion inh ibitors such as distortion and noise. ' Studie s addressing the effect of cochlear implants on telephone performance are sparse . There were, however, so me investigations in the 1980s and 1990 s that documented successful teleph one use following impl antatio n. 2 • 8 Most of these studies focused on the telephone performance of patients who used the Nucleus 22 implant (Cochlear Corp .; Lane Cove, New South Wales, Australia):
• Brown et al repor ted the case of an adult multichannel coc hlear implant user who was able to correctly repeat 21% of the key words on the Central Institute for the Deaf (CID) Every day Sentences Tes t spoken over the telephone on the first attempt. 3 When the sentences were repeated, the patient' s accuracy increased to 47 %.
• In a study of 28 elderly patients, Kelsall et al reported successful teleph one use without the assis tance of a telephone code by 6 patients (21%). 4 • Faceret al studied telephone use in 43 postlinguistically deaf adult s who had a Nucleus 22 implant and found that telephone use was possible in 33 (77 %).5 Three other patients were able to use the telephone with the ass istance of a code , and I was able to use the teleph one to a limited degree.
• Cohen et al selected 8 of their adult Nucleus 22 recipie nts who demo nstrated any degree of open-set speech discrimination for eva luation .' Five demonstrated competency in telephone communica tion.
• In a study by Ito et al, 10 of 10 adult Nucle us 22 cochlear imp lant recip ients who performed in the SPEAK coding strategy were able to easi ly understand natural voice conversations ." However, when these patients were eva luated for telephone listening abil ity, their performance was not satisfactory witho ut the ass istance of a telephone adapter.
• Cochlear Corp. studied long-distance telephone speech recogni tion in 67 postlinguistically deaf adults who used the Nucleus 24 coc hlear implant .' Imp rovement over preoperative performan ce with hearing aids was noted in 6 1 patients ( 
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• In a study of 47 adults with a Clarion Multi-Strategy Cochl ear Implant (Adva nced Bionics Corp.; Sylmar, Calif.), Lalwani et al noted that two-thirds understood at least 50 % of the material on the Overlearned Sentences Test transmitted via telephone. " Half of these patien ts understood at least 75% of the material.
• In a more recent study at the authors ' institution, 8 postlin guistically deaf adults implanted with the MED-EL Combi 40+ device (MED-EL; Innsbru ck, Austria) programmed in the CIS mode achieved a mean score of 87% on the CID Telephone Sentences Test transmitted via a standard telephone after 12 months of impl ant use; 5 of these patients achieve d scores of 96 % or higher, includ ing 2 who achieved 100% accuracy."
In this article, we describ e the results of our study of teleph one use among cochlear implant recipients. Our goals were (1) to identify patients at our institut ion who were able to use the telephone indep endentl y and examin e their clin ical, audiologic, and cochlear implant device characteristic s and (2) to ident ify charac teristics associated with the best perform ances on the CID Telephone Sentences Tes t.
Patients and methods
Patient selection. We accessed the patient database at the Depa rtment of Otolaryngology-Head and Neck Surgery at our institution to identify all patients who had undergone cochlear implantation between Jan. I, 1987, and Feb . 28, 200 1. All surgeries had been performed by 1 of 2 implanting surgeo ns during that time. All patients had been born prior to Dec. 3 1, 1991. Prior to testing, all patients had used their cochlear implant for at least 6 month s.
Ninety-five patients met our inclusion criteria and were eligible for this study. We mailed questionnaires to all 95 patients soliciting information on telephone use, demograph ics, medical history (e.g., details on hearing loss and use of hearing aids), and cochlear implant factors.
Data analysis. Response data were recorded and organized on a spreadsheet (Microsoft Excel 2000; Microsoft Corp. ; Redmond , Wash.) . Results were analyzed by SAS software version 8 (SAS Institute; Cary , N.C.).
To obtain a descr iptive profile of the entire sample, responses were tabulated on the basis of sex; age at the time of the survey and at the onset of the hearing loss; the duration and etiology of the hearing loss; the duration of hearing aid use and the side amplified; self-pe rceive d type of hearing aid user; the cochlear implant model and the Volume 83 , Number 2 side implanted; the duration of coc hlear implant use; the type of speec h processor that the patient preferred for genera l conversation and for teleph one conversation; and the contex t in which the patient used the telephone.
A subgro up of patients was selected for further study, and data on them were collected for all of these parameters except for the type of speech processor and the context of telephone use.
Differences between groups were statistically tested according to the general linear model procedure (statistical significance: p<0.0 5). Our protocol was approved by our parent institution's Office of Research Subjects Protection.
Results
Survey responses. Of the 95 surveys mailed, we received responses from 86 patien ts (91%)-50 females (58%) and 36 males (42%).
Type of telephone use. On the basis of their selfreported telephone use, the 86 respondents were assig ned to one of three groups: nonusers (n = 38 [44%]), assist ed users (n = 12 [14%]), and independent users (n = 36
[42%]). Nonusers were defined as patients who engaged in no direct verbal telephone use. Ass isted users were defined as those who were able to use the telephon e with the assistance of an adapte r. Independent users were those who were able to comm unicate on standard and cellular telephones witho ut assistance.
Sex. Most males (57%) were nonusers, while a pluralit y of fema les (48%) were independen t users.
Age at the time ofthe survey. Patients' ages at the time of the survey ranged 10 to 88 years (nonuser mean: 45.9; assisted user mean: 25.5; independent user mean: 29.2) . Independent use was reporte d by 20 of 30 pediatric (age: < 18 yr) patients (67%), but by only 16 of 56 adults (29%).
Age at the onset of hearing loss. Patients' ages at the onset of hearing loss ranged from birth to 67 years (nonuser mea n: 21 yr; assisted user mean: 27; independent user mean : 9.7).
Duratio n ofhearing loss. The duration of hearing loss ranged from I to 62 years (nonuser mean: 25; assisted user mean: 27; independent user mean : 19).
Etiology ofhearing loss. Variou s etiologies of hearing loss were represented across all groups (table) .
Duratio n of hearing aid use. The duration of hearing aid use prior to cochlear implantation ranged from 1 to 58 years and was similar across the three gro ups. One independent user reported no hearing aid use, but in fact this patient had been fitted with clinic-loaned hearing aids 6 months prior to implantation.
Side ofamplification. Preoperative ly, most patients had used binaural amplification systems (68% of nonusers; 75% of assisted users; 8 I% of independent users).
ADA MS, HASE NSTAB , PIPPIN, SISMANIS Side ofimplantation. The right ear had been implanted in 56 of the 86 patients (65%); the right was the most common side in all three groups.
Duration of implant use. The duration of cochlear implant use ranged from 6 months to 14 years (nonuser mean: 6. 1 yr; assisted user mean: 7.4; independent user mean: 4.7).
Type of speec h processor. Some 29 of 38 nonusers (76%) and 10 of 12 assisted users (83%) preferred the body-worn model of speech processor for natural voice communication; 21 of the 36 independent users (58%) preferred the ear-level processor. For telephone communication , however, only 14 of the 36 independent users (39%) preferred the ear-level processor; 15 independent users (42%) preferred the body-worn processor for telephone communication, and 7 (19%) used both.
Context oftelephone use. Of the 48 patients who were either assisted users or independent users, 26 (54%) said they used the telephon e to conduct daily affairs, and 47 (98%) used the telephone for social conversations. Eighteen of these patient s (38%) were employed, including 10 who used the telephone on the job.
Study of independent users. Of the 36 indep endent users , 34-21 females and 13 males, aged 10 to 71 years-accepted our invitation to participate in a telephone listening task. Each patient was placed in a room with a standard land-lin e telephone and given instructions by a member of the study team. The participant was asked to repeat sentences presented from two randomly selected lists that make up the cm Telephone Sentences Test. The sentences were spoken by another study team member from a remote telephone elsewhere in the hospital.
Responses were scored , averaged for the two lists, and ranked according to performance. An average score of90 to 100% was designated as a very good performance, an average of 80 to 89% was classified as good, and the rest were classified asfair. Inorder to ensure consi stency, the same speaker, room, and telephones were used during all tests.
Test results. The mean score of the group as a whole was 67%. Nine patients (26%) were classified as very good (mean age: 38.4),4 (12 %) as good (mean age: 29.8) , and 21 (62%) asfair (mean age: 23.5).
Sex. Group analy sis based on sex revealed that males achieved a better performance than females. Nine of the 13 males (69%) achieve d either velY good or good performances, while 17 of the 2 1 females (8 1%) registered only afair score.
Age at the time of the survey. Adults fared better than children. Eight of the 14 adults (57%) were classified as either very good or good, whereas 15 of the 20 children (75%) were classified as f air.
Age at the onset of hearing loss. Patients' ages at the time of hearing loss ranged from 0 to 47 years (very good mean: 13.5; good mean: 9.7;fair mean: 6.7).
Duration ofhearing loss. The duration of hearing loss ranged from 3 to 59 years (very good mean: 24.9; good mean: 19.9;f air mean: 16.8).
Etiology ofthe hearing loss. No trend s in etiology were evident among the three groups.
Duration of hearin g aid lise. The duration of hearing aid use ranged from 0 to 38 years (very good mean : 14.7; good mean: 15.5;fair mean: 9.7). Step 1:
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Self-perceived type ofhearing aid user. Among the 13 patient s in the vel}' good and good groups combined, 11 (85%) described themse lves as excellent or good hearing aid users prior to impl ant ation, as did 14 of20 (70%) in the fai r group (I fair patient did not answer this que stion ). Th e correlation between performance score and selfperceived type of hearing aid user was statistically significa nt (p<0 .0181 ).
Type of cochlear implant . The Nucleus 22 implant was used by 20 patient s, the MED-EL Combi 40+ implant by 12 patients, and the Nucleus 24 implant by 2 patients. Am ong the Nucleus 22 implant users , 4 were in the combined vel}' good/good group and 16 were in thefair gro up. Am ong the MED-EL Combi 40+ implant users , 9 were in the very good/good group and 3 were in thefair gro up. Both patients who used the Nucleus 24 impl ant were in thefair group.
Side of implantation. Right-side implants were report ed by 22 of the 34 patient s (65%) .
Duration of implantation. The duration of cochlear impl ant use ranged from 6 month s to 14 years and tended to be shorte r in pati ent s with better performances (very good mean: 2.2 yr; good mean: 5.5;fair mean: 5.9 ).
Discussion
Our result s support the findings of earlier studies that telephone communication is possible for many cochlear impl ant patients. The percentage of patients in our study who were independent users (42%) is comparable with percentages reported in previous studies.v ' We also found a wide range in the degree of telephone sentence understanding as measured by the CID Telephone Sentenc es Te st among the independent users. It is noteworthy that a poor performance on this test did not preclud e teleph one use, since 8 of the 34 independent users (24%) sco red less than 50 %. It is likely that other fac tors, such as familiarity with speakers and topics, play a role in successful teleph one communication. The importance of familiar aspec ts is supported by the observation that the telephone was used more for social purposes than for co nducting daily affai rs or for job-related purposes.
One factor that was highl y releva nt to better telephone performance was the patient s' self-assessment of the quality of their hearin g aid use prior to implantation. A ltho ugh all 86 pati ent s "fa iled" the preoperative audio logic test protocol and met other criteria nece ssary for cochlear implantation, 34 (40%) still viewed their experience with hearing aids as beneficial. We speculate that such favorable self-assess ments are a function of a motivated personality, and moti vation has been found to 102 play an important role in achieving teleph one co mpetence.' In addition, Aronson et al studied the use of routin e teleph one training in aura l habilitation of a pedi atric population." The y found that this type of interve ntion might be successful am ong patient s who are relatively les s moti vated to acquire telephone skills on their own.
Ano ther factor associ ated with better telephone performance was the type of cochl ear impl ant itself. Patients who used the MED-EL Combi 40+ implant performed at a sup erior level. However, we must acknowledge that our study is limited to some degree by the small number of patients in the independent user group (n =36). In addition , there was suboptimal repr esentation of all currently available devices. For example, the Clarion implant was used in only 2 of our 86 patients (2%) . Many of our institution's Clarion patients eithe r did not return their survey or did not meet our inclu sion criteria.
Other trend s are worthy of comment. Among the 86 patients, independent use was repo rted by a higher percentage ofpediatric patients than adults. How ever , am ong the se independent users, the adults achieved higher overall scores on the CID Telephone Sentences Test. A similar pattern was noted in the analy sis of patient sex. Although the females had a higher pre valence of independent use, the y had lower test scores .
Although the duration of hearin g loss was not a statistically significant factor in cm Telephone Sentences Te st scores (p<0.08), the very good group was well represented by patients with longer durations of hearing loss. Thi s observation contradicts findings reported by Lalwani et ai, who indicated that patients whose performances were poor had longer durations of hearing loss." It is interesting that independent users tended to have a shorter duration of cochlear implant use than nonusers and assisted users. So did those with higher CID Telephone Sentences Te st scores. We hypothesize that the reason for this is that the newer devices offer improved technology and prog ramming options.
We also noted that the independent users who had Nucl eus 22 implants preferred to use their ear-level units for general communica tion and their bod y-le vel processors for telephone co mmunication. The MED-EL Combi 40+ patient s indicated that overall performance was better with thei r Temp o-s ear-leve l mode ls.
Our findings sugges t that many cochl ear impl ant patient s can use the teleph one durin g daily activ ity without the need for assistive de vices or relay services . Accord ing to our study, a typical good performer is an adult male who was relativel y older when he lost his hearin g but who has already experienced a rel atively longer duration of hearing loss; he had previously worn a high-quality hearin g aid , and he received a MED-EL Combi 40+ implant a relatively short time ago . .
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